Skip Navigation



JAC Advance Access published online on December 6, 2007

Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkm471
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
61/2/296    most recent
dkm471v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cagnacci, S.
Right arrow Articles by Rossolini, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cagnacci, S.
Right arrow Articles by Rossolini, G. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Bloodstream infections caused by multidrug-resistant Klebsiella pneumoniae producing the carbapenem-hydrolysing VIM-1 metallo-β-lactamase: first Italian outbreak

Simone Cagnacci1, Laura Gualco1, Simona Roveta1, Stefania Mannelli1, Luisa Borgianni2, Jean-Denis Docquier2, Ferdinando Dodi3, Monica Centanaro4, Eugenio Debbia1, Anna Marchese1,* and Gian Maria Rossolini2

1 Di.S.C.A.T., Microbiology Unit, University of Genoa, Genoa, Italy 2 Department of Molecular Biology, Microbiology Unit, University of Siena, Siena, Italy 3 Department of Infectious Diseases, S. Martino Hospital, Genoa, Italy 4 Department of Anaesthesiology—Critical Care, S. Martino Hospital, Genoa, Italy

Received 28 August 2007; returned 23 September 2007; revised 9 November 2007; accepted 13 November 2007


* Corresponding author. Tel: +39-010-3537502; Fax: +39-010-3537655; E-mail: anna.marchese{at}unige.it

Objectives: To investigate the first Italian outbreak of bloodstream infections caused by multidrug-resistant (MDR) Klebsiella pneumoniae producing metallo-β-lactamase (MBL), which occurred in three wards of one large tertiary-care hospital in Genoa, Italy, from September 2004 to March 2005.

Methods: MBL production was screened by an imipenem–EDTA disc synergy test and confirmed by a conventional hydrolysis test. Antibiotic susceptibility was determined by broth microdilution or disc diffusion. PFGE was used to study the genetic relatedness of isolates. PCR and sequencing were carried out to identify the β-lactamase genes and to analyse the genetic context of the MBL gene. Outer membrane protein (OMP) profiles were analysed by SDS–PAGE.

Results: Nine cases of bloodstream infections caused by an MDR strain of K. pneumoniae producing the VIM-1 MBL and the SHV-5 extended-spectrum β-lactamase (ESBL) were identified. The isolates exhibited various carbapenem resistance levels (imipenem MICs ranged from 4 to 64 mg/L) and were resistant to other β-lactams, fluoroquinolones, trimethoprim/sulfamethoxazole and chloramphenicol. The isolate with the highest imipenem MIC also lacked the k36 OMP. The blaVIM-1 gene cassette was part of the variable region of a class 1 integron that also included an aac(6')-IIc cassette. The ESBL and MBL genes were transferable by conjugation.

Conclusions: This is the first report on the emergence of an MDR strain of K. pneumoniae producing the VIM-1 MBL, causing an outbreak of bloodstream infections in an Italian hospital. The strain evolved through OMP alterations generating a mutant with increased carbapenem resistance.

Key Words: carbapenem resistance , carbapenemases , extended-spectrum β-lactamases , class 1 integrons


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Clin. Microbiol.Home page
M. Falcone, M. L. Mezzatesta, M. Perilli, C. Forcella, A. Giordano, V. Cafiso, G. Amicosante, S. Stefani, and M. Venditti
Infections with VIM-1 Metallo-{beta}-Lactamase-Producing Enterobacter cloacae and Their Correlation with Clinical Outcome
J. Clin. Microbiol., November 1, 2009; 47(11): 3514 - 3519.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
N. al Naiemi, M. C. Rijnsburger, P. H. M. Savelkoul, C. M. J. Vandenbroucke-Grauls, and Y. J. Debets-Ossenkopp
Emergence of metallo-{beta}-lactamases in the Netherlands
J. Med. Microbiol., October 1, 2009; 58(10): 1398 - 1399.
[Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
G. M. Rossolini, F. Luzzaro, R. Migliavacca, C. Mugnaioli, B. Pini, F. De Luca, M. Perilli, S. Pollini, M. Spalla, G. Amicosante, et al.
First Countrywide Survey of Acquired Metallo-{beta}-Lactamases in Gram-Negative Pathogens in Italy
Antimicrob. Agents Chemother., November 1, 2008; 52(11): 4023 - 4029.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
A. Carrer, L. Poirel, H. Eraksoy, A. A. Cagatay, S. Badur, and P. Nordmann
Spread of OXA-48-Positive Carbapenem-Resistant Klebsiella pneumoniae Isolates in Istanbul, Turkey
Antimicrob. Agents Chemother., August 1, 2008; 52(8): 2950 - 2954.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
S. Cagnacci, L. Gualco, E. Debbia, G. C. Schito, and A. Marchese
European Emergence of Ciprofloxacin-Resistant Escherichia coli Clonal Groups O25:H4-ST 131 and O15:K52:H1 Causing Community-Acquired Uncomplicated Cystitis
J. Clin. Microbiol., August 1, 2008; 46(8): 2605 - 2612.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.